Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany

Published:2016-10-18 Issue:12 Volume:57 Page:2056-2066
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Kortland Lena-Marie¹²,Alfter Anne¹,Bähr Oliver³,Carl Barbara⁴,Dodel Richard²⁵,Freiman Thomas M.⁶,Hubert Kristina¹,Jahnke Kolja¹,Knake Susanne²,von Podewils Felix⁷,Reese Jens-Peter⁸,Runge Uwe⁷,Senft Christian⁶,Steinmetz Helmuth¹,Rosenow Felix¹²,Strzelczyk Adam¹²^ORCID

Affiliation:

1. Department of Neurology; Epilepsy Center Frankfurt Rhine-Main; Goethe-University; Frankfurt am Main Germany

2. Epilepsy Center Hessen and Department of Neurology; Philipps-University; Marburg Germany

3. Senckenberg Institute of Neurooncology; Goethe-University; Frankfurt am Main Germany

4. Department of Neurosurgery; Philipps-University; Marburg Germany

5. Department of Geriatrics; University Duisburg-Essen; Essen Germany

6. Department of Neurosurgery; Goethe-University; Frankfurt am Main Germany

7. Department of Neurology and Epilepsy Center; Ernst-Moritz-Arndt-University; Greifswald Germany

8. Institute of Health Service Research and Clinical Epidemiolgy and Coordinating Center for Clinical Trials; Philipps-University; Marburg Germany

Funder

Epilepsie-Förderverein Hessen e.V.

UCB Pharma, Monheim

Eisai

Desitin Arzneimittel

Novartis

Medtronic

Cerbomed

Viropharma

Sandoz

Sage Therapeutics and Shire

European Union

Deutsche Forschungsgemeinschaft

Bayer HealthCare

Boehringer Ingelheim

Pfizer

Baxter International

Faber-Stiftung

Hector-Stiftung

AOK Gesundheitskasse Hessen

AOK Gesundheitskasse Sachsen und Thüringen

Lundbeck

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/epi.13584/fullpdf

Reference40 articles.

1. Cost of epilepsy: a systematic review;Strzelczyk;Pharmacoeconomics,2008

2. The economic impact of epilepsy: a systematic review;Allers;BMC Neurol,2015

3. The direct cost of epilepsy in the United States: a systematic review of estimates;Begley;Epilepsia,2015

4. Cost of disorders of the brain in Europe 2010;Gustavsson;Eur Neuropsychopharmacol,2011

5. Inpatient treatment costs of status epilepticus in adults in Germany;Strzelczyk;Seizure,2013

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends and Differences in Status Epilepticus Treatment of Children and Adults Over 10 Years: A Comparative Study of Medical Records (2012–2021) from a University Hospital in Germany;CNS Drugs;2023-11

2. Outcomes and Treatment Approaches for Super-Refractory Status Epilepticus;JAMA Neurology;2023-09-01

3. How much refractory is ‘refractory status epilepticus’? A retrospective study of treatment strategies and clinical outcomes;Journal of Neurology;2023-08-16

4. Clinical characteristics and outcomes of patients with recurrent status epilepticus episodes;Neurological Research and Practice;2023-07-13

5. Evidence-based guideline on management of status epilepticus in adult intensive care unit in resource-limited settings: a review article;Annals of Medicine & Surgery;2023-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3